Long acting injectable crystal formulations of estradiol metabolites and methods of using same

Details for Australian Patent Application No. 2005284714 (hide)

Owner PR Pharmaceuticals, Inc.

Inventors Allison, S. Dean

Agent Davies Collison Cave

Pub. Number AU-A-2005284714

PCT Pub. Number WO2006/032026

Priority 60/609,632 13.09.04 US

Filing date 13 September 2005

Wipo publication date 23 March 2006

International Classifications

A61K 31/566 (2006.01) - having an oxo group in position 17, e.g. oestrone

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/032026 Priority application(s): WO2006/032026

13 August 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005284727-Compositions and their uses for lysosomal enzyme deficiencies

2005284713-Food quality indicator